{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:36Z","timestamp":1793089116021,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.semdp.2021.12.003","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:00:28Z","timestamp":1641034828000},"page":"239-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists"],"prefix":"10.1053","volume":"39","author":[{"given":"Atif","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisindhu","family":"Narala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.semdp.2021.12.003_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cup.13115","article-title":"A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin","volume":"45","author":"Muzumdar","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2021.12.003_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.humpath.2013.02.007","article-title":"Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update","volume":"45","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2021.12.003_bib0003","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/modpathol.2013.162","article-title":"A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma","volume":"27","author":"Weissinger","year":"2014","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2021.12.003_bib0004","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.5858\/arpa.2012-0284-OA","article-title":"Gould Rothberg BE. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas","volume":"137","author":"Viray","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1053\/j.semdp.2021.12.003_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0344-0338(00)80072-2","article-title":"T311\u2013an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues","volume":"196","author":"Jungbluth","year":"2000","journal-title":"Pathol Res Pract"},{"issue":"8","key":"10.1053\/j.semdp.2021.12.003_bib0006","first-page":"1658","article-title":"Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers","volume":"6","author":"Guo","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1053\/j.semdp.2021.12.003_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13000-015-0431-9","article-title":"A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"10","author":"Uguen","year":"2015","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2021.12.003_bib0008","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/DAD.0000000000001379","article-title":"Observational study examining the diagnostic practice of Ki67 staining for melanocytic lesions","volume":"41","author":"Vyas","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"10.1053\/j.semdp.2021.12.003_bib0009","doi-asserted-by":"crossref","first-page":"815","DOI":"10.5858\/arpa.2017-0435-RA","article-title":"Immunohistochemical expression of p16 in melanocytic lesions: an updated review and meta-analysis","volume":"142","author":"Koh","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1053\/j.semdp.2021.12.003_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.prp.2015.01.003","article-title":"Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivity","volume":"211","author":"Piana","year":"2015","journal-title":"Pathol Res Pract"},{"issue":"10","key":"10.1053\/j.semdp.2021.12.003_bib0011","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jclinpath-2018-205216","article-title":"p16","volume":"71","author":"Serra","year":"2018","journal-title":"J Clin Pathol"},{"issue":"45","key":"10.1053\/j.semdp.2021.12.003_bib0012","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/onc.2011.162","article-title":"In melanoma, beta-catenin is a suppressor of invasion","volume":"30","author":"Arozarena","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1053\/j.semdp.2021.12.003_bib0013","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-017-00758-3","article-title":"Combined activation of MAP kinase pathway and \u03b2-catenin signaling cause deep penetrating nevi","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"10.1053\/j.semdp.2021.12.003_bib0014","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/PAS.0000000000001513","article-title":"Diagnostic utility of LEF1 immunohistochemistry in differentiating deep penetrating nevi from histologic mimics","volume":"44","author":"Raghavan","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2021.12.003_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00428-019-02533-9","article-title":"\u03b2-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors","volume":"474","author":"de la Fouchardi\u00e8re","year":"2019","journal-title":"Virchows Arch Int J Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.12.003_bib0016","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/DAD.0000000000001885","article-title":"Preferentially expressed antigen in melanoma immunostaining in a series of melanocytic neoplasms","volume":"43","author":"Googe","year":"2021","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.12.003_bib0017","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME Expression in Melanocytic Tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2021.12.003_bib0018","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/cup.13818","article-title":"PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2021.12.003_bib0019","article-title":"Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms","author":"McBride","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2021.12.003_bib0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cup.13876","article-title":"PRAME expression in 155 cases of metastatic melanoma","volume":"48","author":"Gradecki","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2021.12.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153105","article-title":"The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma","volume":"216","author":"See","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"9","key":"10.1053\/j.semdp.2021.12.003_bib0022","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/cup.14000","article-title":"The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors","volume":"48","author":"Alomari","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2021.12.003_bib0023","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cup.13958","article-title":"The utility of PRAME staining in identifying malignant transformation of melanocytic nevi","volume":"48","author":"Lohman","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2021.12.003_bib0024","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/cup.13812","article-title":"Diffuse PRAME expression is highly specific for malignant melanoma in the distinction from clear cell sarcoma","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2021.12.003_bib0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/his.14312","article-title":"PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna","volume":"78","author":"Gradecki","year":"2021","journal-title":"Histopathology"},{"issue":"4","key":"10.1053\/j.semdp.2021.12.003_bib0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PAS.0000000000001393","article-title":"Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.12.003_bib0027","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1245\/s10434-012-2475-3","article-title":"Sentinel lymph node biopsy for melanoma: American society of clinical oncology and society of surgical oncology joint clinical practice guideline","volume":"19","author":"Wong","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2021.12.003_bib0028","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jcp.57.1.64","article-title":"Histopathological patterns of melanoma metastases in sentinel lymph nodes","volume":"57","author":"Murray","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.12.003_bib0029","article-title":"AJCC cancer staging system","year":"2020","journal-title":"American College of Surgeons"},{"issue":"4","key":"10.1053\/j.semdp.2021.12.003_bib0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5858\/arpa.2014-0077-OA","article-title":"A Newly Developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas","volume":"139","author":"Tacha","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1053\/j.semdp.2021.12.003_bib0031","article-title":"Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases","volume":"35","author":"Pa","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2021.12.003_bib0032","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/PAS.0000000000000769","article-title":"Reduced H3K27me3 expression is common in nodular melanomas of childhood associated with congenital melanocytic nevi but not in proliferative nodules","volume":"41","author":"Busam","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.12.003_bib0033","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/cup.14091","article-title":"Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi","volume":"48","author":"Gill","year":"2021","journal-title":"J Cutan Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:23:13Z","timestamp":1760037793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257021000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0740257021000964"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2021.12.003","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}